Autologous Cell Therapy Market Estimated to Grow USD 34.7 Billion by 2027, Rising at a 18.1% CAGR- Transparency Market Research, Inc. [Yahoo! Finance]
Vericel Corporation (VCEL)
Last vericel corporation earnings: 2/25 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vcel.com/investor-relations
Company Research
Source: Yahoo! Finance
Wilmington, Delaware, United States, Transparency Market Research Inc. , Aug. 21, 2024 (GLOBE NEWSWIRE) -- According to Transparency Market Research (TMR) , the global autologous cell therapy market value (??? ?? ??? ?? ??) is estimated to total US$ 34.7 Billion by the end of at a whopping CAGR of from 2019 to Autologous cell therapy is a form of medical treatment that utilizes a patient's cells to repair or replace damaged or diseased tissue. This alternative therapy varies from allogeneic cell therapy, which uses cells from another donor. Autologous Cell Therapy Market Overview When patients receive autologous therapy, their cells—such as immune or stem cells—are typically altered from their body and are separately grown or modified in a lab before being reinjected. Consequently, a variety of illnesses, including cancer, autoimmune disorders, and heart disease, may be treated using autologous cell therapy. This particular cell therapy can potentially treat or cure a wide
Show less
Read more
Impact Snapshot
Event Time:
VCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCEL alerts
High impacting Vericel Corporation news events
Weekly update
A roundup of the hottest topics
VCEL
News
- Vericel Co. (NASDAQ: VCEL) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024GlobeNewswire
- Vericel Co. (NASDAQ: VCEL) had its price target raised by analysts at TD Cowen from $55.00 to $60.00. They now have a "buy" rating on the stock.MarketBeat
- Vericel announces FDA approval, commercial availability of MACI Arthro [Seeking Alpha]Seeking Alpha
- Vericel Announces FDA Approval and Commercial Availability of MACI ArthroGlobeNewswire
VCEL
Earnings
- 8/1/24 - In-Line
VCEL
Sec Filings
- 9/20/24 - Form 4
- 9/18/24 - Form 144
- 9/13/24 - Form 4
- VCEL's page on the SEC website